Diverse subsets of endothelial progenitor cells (EPCs) are used for the treatment of ischemic
diseases in clinical trials, and circulating EPCs levels are considered as biomarkers for …

Endothelial barrier integrity is required for maintaining vascular homeostasis and fluid
balance between the circulation and surrounding tissues and for preventing the …

Vascular endothelial growth factors (VEGFs) have been shown to participate in
atherosclerosis, arteriogenesis, cerebral edema, neuroprotection, neurogenesis …

Accumulating evidence indicates the impact of endothelial progenitor cells (EPCs) in
vascular repair. In patients, the number of EPCs is negatively correlated with the severity of …

The important role of the vascular endothelium in cardiovascular health is increasingly
recognized. However, mature endothelial cells possess limited regenerative capacity. There …

Accumulating laboratory studies have implicated the mobilization of bone marrow (BM)-
derived stem cells in brain plasticity and stroke therapy. This mobilization of bone cells to the …

Background and Purpose—Increased circulating endothelial progenitor cells (EPC) have
been associated with a low cardiovascular risk and may be involved in endothelial cell …

Background and Purpose—Endothelial progenitor cells (EPCs) migrate from bone marrow
to systemic circulation in response to tissue ischemia where they differentiate into mature …

The ideal way to prevent and cure atherosclerosis and the subsequent end organ damage is
to restore and rejuvenate the dysfunctional vasculature and the damaged organs. Various …

Aims Circulating progenitor cells are believed to participate in cardiovascular (CV)
homeostasis and their exhaustion has been linked to CV damage. As general agreement on …